Amgen (AMGN) |
United States |
$179.377B |
17.95 |
Regeneron Pharmaceuticals (REGN) |
United States |
$130.594B |
30.84 |
Vertex Pharmaceuticals (VRTX) |
United States |
$127.990B |
0.00 |
Bristol Myers Squibb (BMY) |
United States |
$101.268B |
36.46 |
CSL (CSLLY) |
Australia |
$100.787B |
0.00 |
Gilead Sciences (GILD) |
United States |
$98.354B |
16.81 |
GSK (GSK) |
United Kingdom |
$91.005B |
10.56 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$33.724B |
0.00 |
Argenex SE (ARGX) |
Netherlands |
$30.934B |
0.00 |
Biogen (BIIB) |
United States |
$29.826B |
12.59 |
Moderna (MRNA) |
United States |
$29.752B |
0.00 |
BioNTech SE (BNTX) |
Germany |
$20.976B |
0.00 |
Illumina (ILMN) |
United States |
$20.932B |
142.83 |
BeiGene (BGNE) |
Cayman Islands |
$18.607B |
0.00 |
Genmab (GMAB) |
Denmark |
$18.386B |
22.98 |
BioMarin Pharmaceutical (BMRN) |
United States |
$17.319B |
51.24 |
Insmed (INSM) |
United States |
$13.141B |
0.00 |
Sarepta Therapeutics (SRPT) |
United States |
$12.949B |
295.17 |
Incyte (INCY) |
United States |
$12.646B |
820.75 |
Bio-Techne Corp (TECH) |
United States |
$11.735B |
45.96 |
Exact Sciences (EXAS) |
United States |
$11.398B |
0.00 |
Legend Biotech (LEGN) |
United States |
$10.492B |
0.00 |
QIAGEN (QGEN) |
Netherlands |
$10.431B |
22.02 |
Bio-Rad Laboratories (BIO.B) |
United States |
$9.108B |
30.17 |
Roivant Sciences (ROIV) |
United Kingdom |
$9.044B |
0.00 |
Vaxcyte (PCVX) |
United States |
$9.014B |
0.00 |
Repligen (RGEN) |
United States |
$8.453B |
129.00 |
Halozyme Therapeutics (HALO) |
United States |
$8.088B |
21.28 |
Ascendis Pharma (ASND) |
Denmark |
$8.062B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$7.743B |
0.00 |
Exelixis (EXEL) |
United States |
$7.425B |
22.83 |
Viking Therapeutics (VKTX) |
United States |
$7.104B |
0.00 |
Cytokinetics (CYTK) |
United States |
$6.716B |
0.00 |
Zealand Pharma (ZLDPF) |
Denmark |
$6.491B |
0.00 |
Blueprint Medicines (BPMC) |
United States |
$6.052B |
0.00 |
Krystal Biotech (KRYS) |
United States |
$5.606B |
375.23 |
Nuvalent (NUVL) |
United States |
$5.516B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$5.233B |
0.00 |
Avidity Biosciences (RNA) |
United States |
$4.831B |
0.00 |
Apellis Pharmaceuticals (APLS) |
United States |
$4.737B |
0.00 |
Alkermes (ALKS) |
Ireland |
$4.685B |
16.45 |
Immunovant (IMVT) |
United States |
$4.523B |
0.00 |
Axsome Therapeutics (AXSM) |
United States |
$4.220B |
0.00 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$4.058B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$4.035B |
66.58 |
Biohaven (BHVN) |
United States |
$3.725B |
0.00 |
Arcellx (ACLX) |
United States |
$3.695B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$3.499B |
0.00 |
Merus (MRUS) |
Netherlands |
$3.478B |
0.00 |
Amicus Therapeutics (FOLD) |
United States |
$3.443B |
0.00 |
IDEAYA Biosciences (IDYA) |
United States |
$3.337B |
0.00 |
Iovance Biotherapeutics (IOVA) |
United States |
$3.263B |
0.00 |
Guardant Health (GH) |
United States |
$3.147B |
0.00 |
SpringWorks Therapeutics (SWTX) |
United States |
$3.098B |
0.00 |
Bavarian Nordic (BVNRY) |
Denmark |
$3.079B |
16.63 |
Xenon Pharmaceuticals (XENE) |
Canada |
$3.056B |
0.00 |
HUTCHMED (China) (HCM) |
Hong Kong, SAR China |
$3.041B |
0.00 |
MoonLake Immunotherapeutics (MLTX) |
Switzerland |
$2.989B |
0.00 |
Kymera Therapeutics (KYMR) |
United States |
$2.986B |
0.00 |
Rhythm Pharmaceuticals (RYTM) |
United States |
$2.891B |
0.00 |
Geron (GERN) |
United States |
$2.863B |
0.00 |
ImmunityBio (IBRX) |
United States |
$2.751B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$2.750B |
92.11 |
Celldex Therapeutics (CLDX) |
United States |
$2.740B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$2.573B |
0.00 |
Twist Bioscience (TWST) |
United States |
$2.533B |
0.00 |
Vericel (VCEL) |
United States |
$2.532B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$2.526B |
16.37 |
CG Oncology (CGON) |
United States |
$2.474B |
0.00 |
Janux Therapeutics (JANX) |
United States |
$2.451B |
0.00 |
Apogee Therapeutics (APGE) |
United States |
$2.303B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$2.279B |
0.00 |
Verona Pharma American Depositary Share (VRNA) |
United Kingdom |
$2.232B |
0.00 |
Beam Therapeutics (BEAM) |
United States |
$2.199B |
0.00 |
Structure Therapeutics (GPCR) |
United States |
$2.181B |
0.00 |
NeoGenomics (NEO) |
United States |
$2.117B |
0.00 |
NovoCure (NVCR) |
Jersey |
$2.104B |
0.00 |
Vera Therapeutics (VERA) |
United States |
$2.074B |
0.00 |
Fortrea Holdings (FTRE) |
United States |
$2.066B |
64.06 |
Mirum Pharmaceuticals (MIRM) |
United States |
$2.057B |
0.00 |
Harmony Biosciences Holdings (HRMY) |
United States |
$2.045B |
18.45 |
Zai Lab (ZLAB) |
China |
$1.986B |
0.00 |
Novavax (NVAX) |
United States |
$1.982B |
0.00 |
Certara (CERT) |
United States |
$1.971B |
64.47 |
Ligand Pharmaceuticals (LGND) |
United States |
$1.933B |
32.86 |
Galapagos (GLPG) |
Belgium |
$1.919B |
0.00 |
Kiniksa Pharmaceuticals (KNSA) |
United Kingdom |
$1.905B |
0.00 |
Akero Therapeutics (AKRO) |
United States |
$1.889B |
0.00 |
Neumora Therapeutics (NMRA) |
United States |
$1.840B |
0.00 |
Arvinas (ARVN) |
United States |
$1.796B |
0.00 |
Immunocore Holdings (IMCR) |
United Kingdom |
$1.795B |
0.00 |
Edgewise Therapeutics (EWTX) |
United States |
$1.758B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$1.749B |
0.00 |
MannKind (MNKD) |
United States |
$1.721B |
62.60 |
Rocket Pharmaceuticals (RCKT) |
United States |
$1.716B |
0.00 |
Keros Therapeutics (KROS) |
United States |
$1.702B |
0.00 |
Nurix Therapeutics (NRIX) |
United States |
$1.623B |
0.00 |
Kura Oncology (KURA) |
United States |
$1.614B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$1.565B |
0.00 |
Disc Medicine (IRON) |
United States |
$1.511B |
0.00 |
Belite Bio (BLTE) |
United States |
$1.490B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$1.470B |
102.00 |
Spyre Therapeutics (SYRE) |
United States |
$1.460B |
0.00 |
Longboard Pharmaceuticals (LBPH) |
United States |
$1.404B |
0.00 |
Sana Biotechnology (SANA) |
United States |
$1.346B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$1.341B |
18.21 |
Gyre Therapeutics (GYRE) |
United States |
$1.286B |
0.00 |
Arcutis Biotherapeutics (ARQT) |
United States |
$1.272B |
0.00 |
Tango Therapeutics (TNGX) |
United States |
$1.268B |
0.00 |
Day One Biopharmaceuticals (DAWN) |
United States |
$1.215B |
0.00 |
Tyra Biosciences (TYRA) |
United States |
$1.202B |
0.00 |
Prothena (PRTA) |
Ireland |
$1.198B |
0.00 |
Cogent Biosciences (COGT) |
United States |
$1.175B |
0.00 |
Cullinan Therapeutics (CGEM) |
United States |
$1.136B |
0.00 |
Vir Biotechnology (VIR) |
United States |
$1.129B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$1.046B |
0.00 |
AnaptysBio (ANAB) |
United States |
$1.045B |
0.00 |
Tarsus Pharmaceuticals (TARS) |
United States |
$1.031B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$1.021B |
0.00 |
MiMedx (MDXG) |
United States |
$1.004B |
28.50 |
Phathom Pharmaceuticals (PHAT) |
United States |
$0.984B |
0.00 |
Praxis Precision Medicines (PRAX) |
United States |
$0.944B |
0.00 |
Immatics (IMTX) |
Germany |
$0.939B |
0.00 |
Viridian Therapeutics (VRDN) |
United States |
$0.938B |
0.00 |
89BIO (ETNB) |
United States |
$0.935B |
0.00 |
Immunome (IMNM) |
United States |
$0.912B |
0.00 |
ArriVent BioPharma (AVBP) |
United States |
$0.898B |
0.00 |
CARGO Therapeutics (CRGX) |
United States |
$0.866B |
0.00 |
Dianthus Therapeutics (DNTH) |
United States |
$0.846B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.844B |
0.00 |
Zymeworks (ZYME) |
United States |
$0.833B |
0.00 |
Castle Biosciences (CSTL) |
United States |
$0.819B |
0.00 |
Erasca (ERAS) |
United States |
$0.816B |
0.00 |
Pliant Therapeutics (PLRX) |
United States |
$0.808B |
0.00 |
Abivax SA (ABVX) |
France |
$0.804B |
0.00 |
Nuvation Bio (NUVB) |
United States |
$0.803B |
0.00 |
Rapport Therapeutics (RAPP) |
|
$0.796B |
0.00 |
Mesoblast (MESO) |
Australia |
$0.770B |
0.00 |
Stoke Therapeutics (STOK) |
United States |
$0.766B |
0.00 |
Cytek Biosciences (CTKB) |
United States |
$0.755B |
0.00 |
AbCellera Biologics (ABCL) |
Canada |
$0.754B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$0.744B |
0.00 |
Oric Pharmaceuticals (ORIC) |
United States |
$0.732B |
0.00 |
Arbutus Biopharma (ABUS) |
United States |
$0.731B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.730B |
0.00 |
Applied Therapeutics (APLT) |
United States |
$0.728B |
0.00 |
Travere Therapeutics (TVTX) |
United States |
$0.724B |
0.00 |
Humacyte (HUMA) |
United States |
$0.722B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$0.716B |
0.00 |
CureVac (CVAC) |
Germany |
$0.703B |
0.00 |
Replimune (REPL) |
United States |
$0.695B |
0.00 |
Adaptive Biotechnologies (ADPT) |
United States |
$0.693B |
0.00 |
Astria Therapeutics (ATXS) |
United States |
$0.690B |
0.00 |
Revance Therapeutics (RVNC) |
United States |
$0.689B |
0.00 |
Olema Pharmaceuticals (OLMA) |
United States |
$0.676B |
0.00 |
Avid Bioservices (CDMO) |
United States |
$0.672B |
0.00 |
Entrada Therapeutics (TRDA) |
United States |
$0.658B |
5.98 |
LENZ Therapeutics (LENZ) |
United States |
$0.643B |
0.00 |
Y-mAbs Therapeutics (YMAB) |
United States |
$0.638B |
0.00 |
Mineralys Therapeutics (MLYS) |
United States |
$0.617B |
0.00 |
ITeos Therapeutics (ITOS) |
United States |
$0.615B |
0.00 |
IGM Biosciences (IGMS) |
United States |
$0.604B |
0.00 |
REGENXBIO (RGNX) |
United States |
$0.604B |
0.00 |
Annexon (ANNX) |
United States |
$0.602B |
0.00 |
Alumis (ALMS) |
United States |
$0.600B |
0.00 |
Celcuity (CELC) |
United States |
$0.591B |
0.00 |
Arcturus Therapeutics Holdings (ARCT) |
United States |
$0.568B |
0.00 |
PureTech Health (PRTC) |
United States |
$0.550B |
0.00 |
Allogene Therapeutics (ALLO) |
United States |
$0.550B |
0.00 |
GH Research (GHRS) |
Ireland |
$0.546B |
0.00 |
Fulcrum Therapeutics (FULC) |
United States |
$0.534B |
0.00 |
Q32 Bio (QTTB) |
United States |
$0.524B |
0.00 |
Pharming Group (PHAR) |
Netherlands |
$0.522B |
0.00 |
Alector (ALEC) |
United States |
$0.514B |
0.00 |
Prime Medicine (PRME) |
United States |
$0.514B |
0.00 |
Anavex Life Sciences (AVXL) |
United States |
$0.510B |
0.00 |
Contineum Therapeutics (CTNM) |
United States |
$0.501B |
0.00 |
Absci (ABSI) |
United States |
$0.500B |
0.00 |
Terns Pharmaceuticals (TERN) |
United States |
$0.493B |
0.00 |
Neurogene (NGNE) |
United States |
$0.486B |
0.00 |
Oculis Holding AG (OCS) |
Switzerland |
$0.486B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.479B |
0.00 |
ACELYRIN, INC (SLRN) |
United States |
$0.477B |
0.00 |
Third Harmonic Bio (THRD) |
United States |
$0.475B |
0.00 |
MaxCyte (MXCT) |
United States |
$0.454B |
0.00 |
Emergent Biosolutions (EBS) |
United States |
$0.440B |
0.00 |
C4 Therapeutics (CCCC) |
United States |
$0.438B |
0.00 |
GRAIL (GRAL) |
United States |
$0.438B |
0.00 |
Mind Medicine (MindMed) (MNMD) |
United States |
$0.437B |
0.00 |
Oxford BioMedica (OXBDF) |
United Kingdom |
$0.426B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.426B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$0.418B |
0.00 |
Aura Biosciences (AURA) |
United States |
$0.394B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$0.390B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.380B |
183.57 |
Monte Rosa Therapeutics (GLUE) |
United States |
$0.379B |
0.00 |
G1 Therapeutics (GTHX) |
United States |
$0.376B |
0.00 |
Nkarta (NKTX) |
United States |
$0.375B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.375B |
0.00 |
Ocugen (OCGN) |
United States |
$0.374B |
0.00 |
Ginkgo Bioworks Holdings (DNA) |
United States |
$0.372B |
0.00 |
Voyager Therapeutics (VYGR) |
United States |
$0.358B |
23.43 |
CorMedix Inc (CRMD) |
United States |
$0.349B |
0.00 |
Inozyme Pharma (INZY) |
United States |
$0.348B |
0.00 |
Kyverna Therapeutics (KYTX) |
United States |
$0.346B |
0.00 |
Alto Neuroscience (ANRO) |
United States |
$0.345B |
0.00 |
Solid Biosciences (SLDB) |
United States |
$0.345B |
0.00 |
XOMA Royalty (XOMA) |
United States |
$0.342B |
0.00 |
Kamada (KMDA) |
Israel |
$0.331B |
21.30 |
Jasper Therapeutics (JSPR) |
United States |
$0.329B |
0.00 |
Urogen Pharma (URGN) |
United States |
$0.326B |
0.00 |
Nautilus Biotechnology (NAUT) |
United States |
$0.326B |
0.00 |
Atea Pharmaceuticals (AVIR) |
United States |
$0.325B |
0.00 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.325B |
0.00 |
AC Immune (ACIU) |
Switzerland |
$0.320B |
0.00 |
PepGen (PEPG) |
United States |
$0.314B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.313B |
0.00 |
Editas Medicine (EDIT) |
United States |
$0.308B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$0.308B |
0.00 |
EnGene Holdings (ENGN) |
Canada |
$0.308B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.301B |
0.00 |
Cartesian Therapeutics (RNAC) |
United States |
$0.298B |
0.00 |
TScan Therapeutics (TCRX) |
United States |
$0.298B |
0.00 |
UniQure (QURE) |
Netherlands |
$0.285B |
0.00 |
Tectonic Therapeutic (TECX) |
United States |
$0.283B |
0.00 |
ADC Therapeutics SA (ADCT) |
Switzerland |
$0.280B |
0.00 |
Corvus Pharmaceuticals (CRVS) |
United States |
$0.280B |
0.00 |
Precigen (PGEN) |
United States |
$0.278B |
0.00 |
Poseida Therapeutics (PSTX) |
United States |
$0.278B |
0.00 |
Zura Bio (ZURA) |
United States |
$0.278B |
0.00 |
Cabaletta Bio (CABA) |
United States |
$0.275B |
0.00 |
Design Therapeutics (DSGN) |
United States |
$0.269B |
0.00 |
Artiva Biotherapeutics (ARTV) |
United States |
$0.269B |
0.00 |
Biomea Fusion (BMEA) |
United States |
$0.265B |
0.00 |
MeiraGTx Holdings (MGTX) |
United States |
$0.264B |
0.00 |
Rezolute (RZLT) |
United States |
$0.264B |
0.00 |
Alpha Teknova (TKNO) |
United States |
$0.263B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.262B |
0.00 |
Amarin (AMRN) |
Ireland |
$0.257B |
0.00 |
ScPharmaceuticals (SCPH) |
United States |
$0.255B |
0.00 |
Orchestra BioMed Holdings (OBIO) |
United States |
$0.253B |
0.00 |
2seventy Bio (TSVT) |
United States |
$0.251B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.247B |
0.00 |
Zentalis Pharmaceuticals (ZNTL) |
United States |
$0.247B |
0.00 |
Trevi Therapeutics (TRVI) |
United States |
$0.229B |
0.00 |
Scilex Holding (SCLX) |
United States |
$0.221B |
0.00 |
Compass Therapeutics (CMPX) |
United States |
$0.217B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.217B |
0.00 |
Candel Therapeutics (CADL) |
United States |
$0.217B |
0.00 |
Tenaya Therapeutics (TNYA) |
United States |
$0.211B |
0.00 |
Inhibrx Biosciences (INBX) |
|
$0.211B |
0.00 |
Molecular Partners AG (MOLN) |
Switzerland |
$0.208B |
0.00 |
Codexis (CDXS) |
United States |
$0.205B |
0.00 |
Gossamer Bio (GOSS) |
United States |
$0.199B |
0.00 |
Caribou Biosciences (CRBU) |
United States |
$0.195B |
0.00 |
XBiotech (XBIT) |
United States |
$0.195B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$0.194B |
0.00 |
Skye Bioscience (SKYE) |
United States |
$0.188B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$0.187B |
0.00 |
Compugen (CGEN) |
Israel |
$0.187B |
0.00 |
Innate Pharma S.A (IPHA) |
France |
$0.186B |
0.00 |
Greenwich LifeSciences (GLSI) |
United States |
$0.184B |
0.00 |
Opthea (OPT) |
Australia |
$0.180B |
0.00 |
BioStem Technologies (BSEM) |
|
$0.180B |
28.26 |
Sangamo Therapeutics (SGMO) |
United States |
$0.177B |
0.00 |
Generation Bio (GBIO) |
United States |
$0.176B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.174B |
0.00 |
Shattuck Labs (STTK) |
United States |
$0.171B |
0.00 |
Rani Therapeutics Holdings (RANI) |
United States |
$0.171B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.168B |
0.00 |
Acumen Pharmaceuticals (ABOS) |
United States |
$0.165B |
0.00 |
ProQR Therapeutics (PRQR) |
Netherlands |
$0.164B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$0.160B |
0.00 |
Ventyx Biosciences (VTYX) |
United States |
$0.158B |
0.00 |
23andMe Holding (ME) |
United States |
$0.154B |
0.00 |
Actuate Therapeutics (ACTU) |
|
$0.154B |
0.00 |
Adherex Technologies (FENC) |
United States |
$0.152B |
139.25 |
Adverum Biotechnologies (ADVM) |
United States |
$0.144B |
0.00 |
ATyr Pharma (ATYR) |
United States |
$0.142B |
0.00 |
Elutia (ELUT) |
United States |
$0.140B |
0.00 |
Vigil Neuroscience (VIGL) |
United States |
$0.138B |
0.00 |
Immunic (IMUX) |
United States |
$0.136B |
0.00 |
Lifecore Biomedical (LFCR) |
United States |
$0.135B |
0.00 |
Cellectis S.A (CLLS) |
France |
$0.133B |
0.00 |
Kodiak Sciences (KOD) |
United States |
$0.132B |
0.00 |
INmune Bio (INMB) |
United States |
$0.131B |
0.00 |
Nuvectis Pharma (NVCT) |
United States |
$0.130B |
0.00 |
Akoya Biosciences (AKYA) |
United States |
$0.126B |
0.00 |
Adagene (ADAG) |
China |
$0.124B |
0.00 |
Repare Therapeutics (RPTX) |
Canada |
$0.124B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.123B |
13.16 |
ALX Oncology Holdings (ALXO) |
United States |
$0.122B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$0.121B |
0.00 |
Adicet Bio (ACET) |
United States |
$0.120B |
0.00 |
Inventiva S.A (IVA) |
France |
$0.119B |
0.00 |
Eton Pharmaceuticals (ETON) |
United States |
$0.119B |
0.00 |
Athira Pharma (ATHA) |
United States |
$0.119B |
0.00 |
X4 Pharmaceuticals (XFOR) |
United States |
$0.118B |
0.00 |
PDS Biotechnology (PDSB) |
United States |
$0.118B |
0.00 |
CervoMed (CRVO) |
United States |
$0.115B |
0.00 |
Eledon Pharmaceuticals (ELDN) |
United States |
$0.111B |
0.00 |
Agenus (AGEN) |
United States |
$0.111B |
0.00 |
Annovis Bio (ANVS) |
United States |
$0.110B |
0.00 |
Cardiff Oncology (CRDF) |
United States |
$0.108B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.107B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.106B |
0.00 |
Adlai Nortye (ANL) |
Cayman Islands |
$0.105B |
0.00 |
Seer (SEER) |
United States |
$0.103B |
0.00 |
Tiziana Life Sciences (TLSA) |
United Kingdom |
$0.103B |
0.00 |
Invivyd (IVVD) |
United States |
$0.102B |
0.00 |
Verastem (VSTM) |
United States |
$0.101B |
0.00 |
IO Biotech (IOBT) |
Denmark |
$0.099B |
0.00 |
Sagimet Biosciences (SGMT) |
United States |
$0.094B |
0.00 |
VistaGen Therapeutics (VTGN) |
United States |
$0.094B |
0.00 |
Werewolf Therapeutics (HOWL) |
United States |
$0.094B |
0.00 |
Regencell Bioscience Holdings (RGC) |
Hong Kong, SAR China |
$0.094B |
0.00 |
InflaRx (IFRX) |
Germany |
$0.094B |
0.00 |
Benitec Biopharma (BNTC) |
United States |
$0.093B |
0.00 |
HilleVax (HLVX) |
United States |
$0.093B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.092B |
8.43 |
Coya Therapeutics (COYA) |
United States |
$0.092B |
0.00 |
I-Mab (IMAB) |
China |
$0.091B |
0.00 |
Instil Bio (TIL) |
United States |
$0.091B |
0.00 |
Semper Paratus Acquisition (TVGN) |
United States |
$0.089B |
0.00 |
Renovaro (RENB) |
United States |
$0.088B |
0.00 |
BioHarvest Sciences (CNVCF) |
Canada |
$0.088B |
0.00 |
Connect Biopharma Holdings (CNTB) |
United States |
$0.088B |
0.00 |
DBV Technologies S.A (DBVT) |
France |
$0.087B |
0.00 |
BioAtla (BCAB) |
United States |
$0.086B |
0.00 |
Cidara Therapeutics (CDTX) |
United States |
$0.084B |
0.00 |
Chimerix (CMRX) |
United States |
$0.084B |
0.00 |
Galena Biopharma (SLS) |
United States |
$0.083B |
0.00 |
Ikena Oncology (IKNA) |
United States |
$0.083B |
0.00 |
Omega Therapeutics (OMGA) |
United States |
$0.081B |
0.00 |
Boundless Bio (BOLD) |
United States |
$0.081B |
0.00 |
Ovid Therapeutics (OVID) |
United States |
$0.080B |
0.00 |
BeyondSpring (BYSI) |
United States |
$0.080B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.079B |
0.00 |
Milestone Pharmaceuticals (MIST) |
Canada |
$0.076B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.075B |
0.00 |
Genelux (GNLX) |
United States |
$0.075B |
0.00 |
Leap Therapeutics (LPTX) |
United States |
$0.074B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.074B |
3.34 |
Oncolytics Biotech (ONCY) |
Canada |
$0.074B |
0.00 |
MediciNova (MNOV) |
United States |
$0.074B |
0.00 |
Rapt Therapeutics (RAPT) |
United States |
$0.072B |
0.00 |
TELA Bio (TELA) |
United States |
$0.072B |
0.00 |
Genenta Science S.p.A (GNTA) |
Italy |
$0.071B |
0.00 |
Eupraxia Pharmaceuticals (EPRX) |
Canada |
$0.070B |
0.00 |
Imunon (IMNN) |
United States |
$0.069B |
0.00 |
Celularity (CELU) |
United States |
$0.068B |
0.00 |
Affimed (AFMD) |
Germany |
$0.064B |
0.00 |
Kronos Bio (KRON) |
United States |
$0.063B |
0.00 |
HOOKIPA Pharma (HOOK) |
United States |
$0.063B |
0.00 |
Allakos (ALLK) |
United States |
$0.063B |
0.00 |
Earth Science Tech (ETST) |
United States |
$0.062B |
0.00 |
Lexaria Bioscience (LEXX) |
Canada |
$0.062B |
0.00 |
Bluebird Bio (BLUE) |
United States |
$0.061B |
0.00 |
CollPlant Biotechnologies (CLGN) |
Israel |
$0.061B |
0.00 |
Intensity Therapeutics (INTS) |
United States |
$0.060B |
0.00 |
Vor Biopharma (VOR) |
|
$0.060B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.060B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.059B |
0.00 |
Immix Biopharma (IMMX) |
United States |
$0.059B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.059B |
0.00 |
FibroBiologics (FBLG) |
United States |
$0.057B |
0.00 |
Gritstone Bio (GRTS) |
United States |
$0.056B |
0.00 |
Aerovate Therapeutics (AVTE) |
United States |
$0.056B |
0.00 |
Aileron Therapeutics (ALRN) |
United States |
$0.055B |
0.00 |
Barinthus Biotherapeutics (BRNS) |
United Kingdom |
$0.052B |
0.00 |
Anebulo Pharmaceuticals (ANEB) |
United States |
$0.050B |
0.00 |
Rallybio (RLYB) |
United States |
$0.048B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.047B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.046B |
0.00 |
Elevation Oncology (ELEV) |
United States |
$0.046B |
0.00 |
Estrella Immunopharma (ESLA) |
United States |
$0.046B |
0.00 |
Akari Therapeutics (AKTX) |
United Kingdom |
$0.046B |
0.00 |
CalciMedica (CALC) |
United States |
$0.045B |
0.00 |
Aadi Bioscience (AADI) |
United States |
$0.045B |
0.00 |
Lantern Pharma (LTRN) |
United States |
$0.044B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.044B |
0.00 |
Kezar Life Sciences (KZR) |
United States |
$0.044B |
0.00 |
Passage Bio (PASG) |
United States |
$0.043B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$0.042B |
0.00 |
LakeShore Biopharma (LSB) |
China |
$0.041B |
0.00 |
NextCure (NXTC) |
United States |
$0.041B |
0.00 |
Elicio Therapeutics (ELTX) |
United States |
$0.041B |
0.00 |
Promis Neurosciences (PMN) |
Canada |
$0.041B |
0.00 |
OKYO Pharma (OKYO) |
|
$0.041B |
0.00 |
Aligos Therapeutics (ALGS) |
United States |
$0.041B |
0.00 |
Prenetics Global (PRE) |
Hong Kong, SAR China |
$0.040B |
0.00 |
Dyadic (DYAI) |
United States |
$0.040B |
0.00 |
Ocean Biomedical (OCEA) |
United States |
$0.039B |
0.00 |
Equillium (EQ) |
United States |
$0.038B |
0.00 |
Xilio Therapeutics (XLO) |
United States |
$0.038B |
0.00 |
Atara Biotherapeutics (ATRA) |
United States |
$0.037B |
0.00 |
Acurx Pharmaceuticals (ACXP) |
United States |
$0.036B |
0.00 |
Eyenovia (EYEN) |
United States |
$0.035B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.035B |
0.00 |
ARCA Biopharma (ABIO) |
United States |
$0.035B |
0.00 |
Clene (CLNN) |
United States |
$0.034B |
0.00 |
AN2 Therapeutics (ANTX) |
United States |
$0.034B |
0.00 |
Curis (CRIS) |
United States |
$0.033B |
0.00 |
Immuneering (IMRX) |
United States |
$0.033B |
0.00 |
Ocuphire Pharma (OCUP) |
United States |
$0.032B |
0.00 |
MiNK Therapeutics (INKT) |
United States |
$0.032B |
0.00 |
Lumos Pharma (LUMO) |
United States |
$0.032B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.031B |
0.00 |
Pluri (PLUR) |
Israel |
$0.031B |
0.00 |
Dare Bioscience (DARE) |
United States |
$0.031B |
0.00 |
NeuroBo Pharmaceuticals (NRBO) |
United States |
$0.030B |
0.00 |
Quince Therapeutics (QNCX) |
United States |
$0.030B |
0.00 |
Achilles Therapeutics (ACHL) |
United Kingdom |
$0.030B |
0.00 |
Longeveron (LGVN) |
United States |
$0.029B |
0.00 |
Chemomab Therapeutics (CMMB) |
Israel |
$0.029B |
0.00 |
Cognition Therapeutics (CGTX) |
United States |
$0.029B |
0.00 |
MIRA Pharmaceuticals (MIRA) |
United States |
$0.029B |
0.00 |
UNITY Biotechnology (UBX) |
United States |
$0.027B |
0.00 |
SAB Biotherapeutics (SABS) |
United States |
$0.027B |
0.00 |
KALA BIO (KALA) |
United States |
$0.027B |
0.00 |
Femasys (FEMY) |
United States |
$0.026B |
0.00 |
Bolt Biotherapeutics (BOLT) |
United States |
$0.026B |
0.00 |
Biora Therapeutics (BIOR) |
United States |
$0.025B |
0.00 |
BioXcel Therapeutics (BTAI) |
United States |
$0.025B |
0.00 |
Brainstorm Cell Therapeutics (BCLI) |
United States |
$0.025B |
0.00 |
IN8bio (INAB) |
United States |
$0.025B |
0.00 |
RenovoRx (RNXT) |
United States |
$0.024B |
0.00 |
GeoVax Labs (GOVX) |
United States |
$0.024B |
0.00 |
Vincerx Pharma (VINC) |
United States |
$0.024B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.024B |
0.00 |
Lisata Therapeutics (LSTA) |
United States |
$0.024B |
0.00 |
Cyclo Therapeutics (CYTH) |
United States |
$0.021B |
0.00 |
Beyond Air (XAIR) |
United States |
$0.021B |
0.00 |
BioAffinity Technologies (BIAF) |
United States |
$0.020B |
0.00 |
NKGen Biotech (NKGN) |
United States |
$0.020B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$0.020B |
0.00 |
Spruce Biosciences (SPRB) |
United States |
$0.019B |
0.00 |
Aprea Therapeutics (APRE) |
United States |
$0.019B |
0.00 |
Cocrystal Pharma (COCP) |
United States |
$0.018B |
0.00 |
HCW Biologics (HCWB) |
United States |
$0.017B |
0.00 |
Synlogic (SYBX) |
United States |
$0.017B |
0.00 |
Evaxion Biotech (EVAX) |
Denmark |
$0.017B |
0.00 |
Turnstone Biologics (TSBX) |
United States |
$0.016B |
0.00 |
CytoMed Therapeutics (GDTC) |
Singapore |
$0.016B |
0.00 |
ANEW Medical (WENA) |
United States |
$0.016B |
0.00 |
Sensei Biotherapeutics (SNSE) |
United States |
$0.015B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.015B |
0.00 |
Virax Biolabs Group (VRAX) |
United Kingdom |
$0.015B |
0.00 |
Aytu BioPharma (AYTU) |
United States |
$0.015B |
0.00 |
Edesa Biotech (EDSA) |
Canada |
$0.015B |
0.00 |
BRIACELL THERAP (BCTX) |
Canada |
$0.014B |
0.00 |
Tenax Therapeutics (TENX) |
United States |
$0.014B |
0.00 |
Evogene (EVGN) |
Israel |
$0.014B |
0.00 |
Carmell (CTCX) |
United States |
$0.013B |
0.00 |
Galecto (GLTO) |
Denmark |
$0.013B |
0.00 |
Purple Biotech (PPBT) |
Israel |
$0.012B |
0.00 |
NeuroSense Therapeutics (NRSN) |
Israel |
$0.012B |
0.00 |
Senti Biosciences (SNTI) |
United States |
$0.012B |
0.00 |
Forte Biosciences (FBRX) |
United States |
$0.012B |
0.00 |
Biorestorative Therapies (BRTX) |
United States |
$0.011B |
0.00 |
Novogen (KZIA) |
Australia |
$0.011B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.011B |
0.00 |
Apollomics (APLM) |
United States |
$0.011B |
0.00 |
Mustang Bio (MBIO) |
United States |
$0.010B |
0.00 |
Kintara Therapeutics (KTRA) |
United States |
$0.010B |
0.00 |
Eterna Therapeutics (ERNA) |
United States |
$0.010B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.010B |
0.00 |
NuCana (NCNA) |
United Kingdom |
$0.010B |
0.00 |
Cardio Diagnostics Holdings (CDIO) |
United States |
$0.009B |
0.00 |
Monopar Therapeutics (MNPR) |
United States |
$0.008B |
0.00 |
ABVC BioPharma (ABVC) |
United States |
$0.008B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.008B |
0.00 |
Cadrenal Therapeutics (CVKD) |
United States |
$0.008B |
0.00 |
Coeptis Therapeutics Holdings (COEP) |
United States |
$0.008B |
0.00 |
Soligenix (SNGX) |
United States |
$0.008B |
0.00 |
Talis Biomedical (TLIS) |
United States |
$0.008B |
0.00 |
Cyclerion Therapeutics (CYCN) |
United States |
$0.008B |
0.00 |
Kineta (KA) |
United States |
$0.008B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.008B |
0.00 |
Cingulate (CING) |
United States |
$0.008B |
0.00 |
Aptose Biosciences (APTO) |
Canada |
$0.007B |
0.00 |
COSCIENS Biopharma (CSCI) |
Canada |
$0.007B |
0.00 |
TFF Pharmaceuticals (TFFP) |
United States |
$0.007B |
0.00 |
Moleculin Biotech (MBRX) |
United States |
$0.007B |
0.00 |
BioCardia (BCDA) |
United States |
$0.006B |
0.00 |
Adial Pharmaceuticals (ADIL) |
United States |
$0.006B |
0.00 |
Telesis Bio (TBIO) |
United States |
$0.006B |
0.00 |
Biofrontera (BFRI) |
United States |
$0.006B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.006B |
0.00 |
Notable Labs (NTBL) |
United States |
$0.006B |
0.00 |
Psyence Biomedical (PBM) |
Canada |
$0.005B |
0.00 |
Quantum Biopharma (QNTM) |
Canada |
$0.005B |
0.00 |
Virios Therapeutics (VIRI) |
United States |
$0.005B |
0.00 |
Elevai Labs (ELAB) |
United States |
$0.005B |
0.00 |
Silo Pharma (SILO) |
United States |
$0.005B |
0.00 |
Bionomics (BNOX) |
Australia |
$0.005B |
0.00 |
Synaptogenix (SNPX) |
United States |
$0.005B |
0.00 |
CNS Pharmaceuticals (CNSP) |
United States |
$0.005B |
0.00 |
Silexion Therapeutics Corp (SLXN) |
United States |
$0.005B |
0.00 |
Hepion Pharmaceuticals (HEPA) |
United States |
$0.005B |
0.00 |
GT Biopharma (GTBP) |
United States |
$0.005B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.005B |
0.00 |
Hoth Therapeutics (HOTH) |
United States |
$0.005B |
0.00 |
Pasithea Therapeutics (KTTA) |
United States |
$0.005B |
0.00 |
Bright Minds Biosciences (DRUG) |
United States |
$0.005B |
0.00 |
Creative Medical Technology Holdings (CELZ) |
United States |
$0.005B |
0.00 |
Enveric Biosciences (ENVB) |
United States |
$0.005B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.004B |
0.00 |
Artelo Biosciences (ARTL) |
United States |
$0.004B |
0.00 |
Citius Oncology (CTOR) |
United States |
$0.004B |
0.00 |
Onconetix (ONCO) |
United States |
$0.004B |
0.00 |
Lixte Biotechnology Holdings (LIXT) |
United States |
$0.004B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.004B |
0.00 |
Avalon GloboCare (ALBT) |
United States |
$0.004B |
0.00 |
Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.004B |
0.00 |
Portage Biotech (PRTG) |
|
$0.004B |
0.00 |
Sunshine Biopharma (SBFM) |
United States |
$0.003B |
0.00 |
Exicure (XCUR) |
United States |
$0.003B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.003B |
0.00 |
Lipella Pharmaceuticals (LIPO) |
United States |
$0.003B |
0.00 |
Trevena (TRVN) |
United States |
$0.003B |
0.00 |
Ensysce Biosciences (ENSC) |
United States |
$0.003B |
0.00 |
Allarity Therapeutics (ALLR) |
United States |
$0.003B |
0.00 |
Invo BioScience (INVO) |
United States |
$0.003B |
0.00 |
Tharimmune (THAR) |
United States |
$0.003B |
0.00 |
TC BioPharm (Holdings) (TCBP) |
United Kingdom |
$0.003B |
0.00 |
ZyVersa Therapeutics (ZVSA) |
United States |
$0.003B |
0.00 |
Atrinsic (PTIX) |
United States |
$0.003B |
0.00 |
Bone Biologics (BBLG) |
United States |
$0.003B |
0.00 |
Dermata Therapeutics (DRMA) |
United States |
$0.002B |
0.00 |
Scinai Immunotherapeutics (SCNI) |
Israel |
$0.002B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.002B |
0.00 |
Alzamend Neuro (ALZN) |
United States |
$0.002B |
0.00 |
Revelation Biosciences (REVB) |
United States |
$0.002B |
0.00 |
GENPREX (GNPX) |
United States |
$0.002B |
0.00 |
180 Life Sciences (ATNF) |
United States |
$0.002B |
0.00 |
Seelos Therapeutics (SEEL) |
United States |
$0.002B |
0.00 |
Virpax Pharmaceuticals (VRPX) |
United States |
$0.002B |
0.00 |
GRI Bio (GRI) |
United States |
$0.001B |
0.00 |
NeuBase Therapeutics (NBSE) |
United States |
$0.001B |
0.00 |
Entero Therapeutics (ENTO) |
United States |
$0.001B |
0.00 |
Biodexa Pharmaceuticals (BDRX) |
United Kingdom |
$0.001B |
0.00 |
Aceragen (ACGN) |
United States |
$0.000B |
0.00 |
Alvotech (ALVO) |
Luxembourg |
$0.000B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.000B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.000B |
0.00 |
LAVA Therapeutics (LVTX) |
Netherlands |
$0.000B |
0.00 |
Motif Bio Plc (MTFB) |
United Kingdom |
$0.000B |
0.00 |
Mainz Biomed (MYNZ) |
Germany |
$0.000B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.000B |
0.00 |
Pharvaris (PHVS) |
Netherlands |
$0.000B |
0.00 |
VectivBio Holding AG (VECT) |
Switzerland |
$0.000B |
0.00 |
Clovis Oncology (CLVSQ) |
United States |
$0.000B |
0.00 |